Hypha Labs Valuation
Is DIGP undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of DIGP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: DIGP ($0.02) is trading below our estimate of fair value ($0.34)
Significantly Below Fair Value: DIGP is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for DIGP?
Other financial metrics that can be useful for relative valuation.
What is DIGP's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$2.29m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | n/a |
Enterprise Value/EBITDA | -45.4x |
PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does DIGP's PB Ratio compare to its peers?
Company | Forward PB | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 5.3x | ||
OTRK Ontrak | 0.5x | 64.7% | US$10.2m |
RSHN RushNet | 6.4x | n/a | US$2.6m |
STRR Star Equity Holdings | 0.3x | 76.0% | US$12.7m |
VVOS Vivos Therapeutics | 13.9x | 22.4% | US$7.4m |
DIGP Hypha Labs | n/a | n/a | US$2.3m |
Price-To-Book vs Peers: DIGP has negative equity and a Price-To-Book Ratio (-4.5x) compared to the peer average (5.3x).
Price to Earnings Ratio vs Industry
How does DIGP's PE Ratio compare vs other companies in the US Healthcare Industry?
Price-To-Book vs Industry: DIGP has negative equity and a Price-To-Book Ratio (-4.5x) compared to the US Healthcare industry average (2.2x).
Price to Book Ratio vs Fair Ratio
What is DIGP's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PB Ratio | -4.5x |
Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate DIGP's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.